Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduce High-risk Behaviours Under Chronic Stress Via tDCS-induced Neural Plasticity

NCT05501951 is registered in ClinicalTrials.gov with LI Cheng as lead sponsor.

NCT NCT05501951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05501951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduce High-risk Behaviours Under Chronic Stress Via tDCS-induced Neural Plasticity
Lead sponsor
LI Cheng
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2022
Completion date
June 30, 2024
Enrollment
255 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stress, risk-taking